Cover Image
Market Research Report

Patient Registry Software Market By Type, Delivery, Functionality, Database, Pricing Model, End User - Global Forecast To 2023

Published by Meticulous Market Research Pvt. Ltd. Product code 671154
Published Content info 253 Pages
Delivery time: 1-2 business days
Price
Back to Top
Patient Registry Software Market By Type, Delivery, Functionality, Database, Pricing Model, End User - Global Forecast To 2023
Published: August 6, 2018 Content info: 253 Pages
Description

Patient Registry Software Market by Type (Diabetes, Cancer, Rare Diseases, CVD, Orthopedic, Drugs, Device), Delivery (On premise, Cloud), Functionality (PHM, HIE, POC, Research), Database (Public, Commercial), Pricing Model, End User - Global Forecast to 2023

Patient registry software market is slated to exhibit lucrative growth rate. Patient registry software market is expected to reach USD 1.49 billion by 2023 from USD 888.6 million in 2018, at a CAGR of 11.0% during the forecast period (2018-2023).

Succeeding an extensive secondary and primary research on patient registry software and in-depth analysis of the market scenario, the report carries out an impact analysis of the key industry drivers, restraints, opportunities, and challenges in the market dynamics segment. Continued pressure to curtail rising healthcare costs, growing demand to improve care quality, implementation of the Affordable Care Act in the U.S., trend towards value-based care, growing use of patient registry data for post-marketing surveillance, improving HCIT infrastructure and adoption of HCIT solutions such as EMRs and HIE, implementation of government initiatives to build patient registries, and rising awareness of population health management are resulting in robust demand for patient registry software across the globe. However, lack of trained/skilled resources, and privacy and data security related concern may hinder the growth of the patient registry software market to some extent.

In addition, the report further gives an extensive outlook on various end users served by the patient registry software market. These end users include government organizations & third-party administrators, hospitals and medical practices, private payers, pharmaceutical, biotechnology, and medical device companies, and research centers. Apart from end users, the report provides insights on adoption of patient registry software in various type of registries, and functionality segment of the market. Moreover, the study offers a comprehensive analysis of patient registry software market with respect to various software type, pricing model, deployment model, and database type.

Further, an in-depth analysis of the geographic scenario of the industry provides detailed qualitative and quantitative insights for the five major geographies (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) along with the coverage of major countries in each region. The geographic analysis provides detailed insights on the key trends of the industry in the listed regions & countries, identifying the demographic & economic impact, and government & private investments. The report identifies North America being the largest market followed by Europe, Asia Pacific, and Rest of World. The geographical analysis section also comments on the key market players shaping the growth of the industry in the respective countries.

The report also includes the competitive landscape based on extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 3.5 years (2015-June 2018). The market players employed various strategies to expand their product offerings, global footprint, and augment their market share. The key strategies followed by most companies in the global patient registry software market include agreements, partnerships, & collaborations; new product launches; mergers & acquisitions; and expansion.

Some of the key players contributing to the growth of the patient registry software market include Phytel, Inc. (U.S.) (an IBM Corporation company), Quintiles IMS Holdings, Inc. (U.S.), Liaison Technologies. (U.S.), ImageTrend, Inc. (U.S.), FIGmd, Inc. (U.S.), McKesson Corporation (U.S.) (Change Healthcare), CECity.com Inc. (U.S.) (A Premier, Inc. company), Dacima Software Inc. (U.S.), Global Vision Technologies, Inc. (U.S.), ifa Systems AG, (Germany), Syneos Health (U.S.), M2S, Inc. (U.S.), Optum, Inc (A part of UnitedHealth Group Inc) (U.S.), EVADO Pty. Ltd. (Australia), and Velos, Inc. (U.S.) among several others.

Key questions answered in the report:

Hospitals and medical centers are driving the adoption of Patient Registry Software

  • How does the penetration of patient registry software differ among various end users?
  • Which are the high growth market segments in terms of registry type, software type, functionality, deployment type, database type, pricing model, and regions/countries?

Population Health Management is the fastest growing application/functionality segment of the Patient Registry Software market

  • What factors are propelling the growth of patient registry software market in population health management?
  • What factors contribute to the growth of patient registry software in medical research?

The North American region is the largest market for patient registry software and includes various global and local players competing in multiple segments

  • Who are the top competitors in this market and what strategies do they employ to gain shares?
  • Which product segments of the patient registry software market are expected to offer lucrative growth in the forecast period and why?
  • What strategies should the new companies focus to enter this market in order sustain and compete with the established players?
  • What are the major drivers, restraints, opportunities, challenges, and trends in the global patient registry software market?
  • What are the geographic trends and high growth regions/countries?

Recent new product launches, partnerships, agreement, expansion, acquisitions that have taken place in the patient registry software space

  • What companies have recently merged/acquired and how will these unions affect the competitive landscape of the patient registry software space?
  • What companies have created partnerships and how will these partnerships promote a competitive advantage?
  • Who are the major players in the global patient registry software and what share of the market do they hold?
  • Who are the local emerging players in the global patient registry software market and how do they compete with the global players?

Scope of the Report

Market, by Registry type

  • Disease Registries
    • Cardiovascular Registries
    • Diabetes Registries
    • Cancer Registries
    • Rare Disease Registries
    • Asthma Registries
    • Chronic Kidney Disease Registries
    • Orthopedic Registries
    • Others
  • Health Service Registries
  • Product Registries
    • Medical Device Registries
    • Drug Registries

Market, by Software Type

  • Standalone Software
  • Integrated Software

Market, by Pricing Model

  • Subscription model
  • Ownership model

Market, by Deployment Model

  • On-premise models
  • Web &Cloud-based models

Market, by Database Type

  • Commercial databases
  • Public databases

Market, by Functionality

  • Population Health Management
  • Patient Care Management
  • Health Information Exchange
  • Point-of-Care
  • Product Outcome Evaluation
  • Medical Research & Clinical Studies

Market, by End User

  • Government Organizations & Third-Party Administrators
  • Hospitals and Medical Practices
  • Private Payers
  • Pharmaceutical, Biotechnology, and Medical Device Companies
  • Research Centers

Market, by Geography

  • North America
  • U.S.
  • Canada
  • Europe
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
  • Japan
  • China
  • India
  • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East & Africa
Table of Contents

Table of Contents

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Ecosystem
  • 1.3. Currency And Limitations
    • 1.3.1. Currency
    • 1.3.2. Limitations
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Process
    • 2.1.1. Secondary Research
    • 2.1.2. Primary Research

3. Executive Summary

4. Market Insights

  • 4.1. Introduction
  • 4.2. Drivers
    • 4.2.1. Rising Pressure To Improve The Quality of Care And Reduce Healthcare Costs
    • 4.2.2. Growing Use of Patient Registry Data For Post-Marketing Surveillance
    • 4.2.3. Rising Adoption of Ehrs
    • 4.2.4. Implementation of Government Initiatives To Build Patient Registries
    • 4.2.5. Rising Focus On Population Health Management
  • 4.3. Restraints
    • 4.3.1. Lack of Skilled Resources
    • 4.3.2. Privacy And Data Security-Related Concerns
  • 4.4. Opportunities
    • 4.4.1. Rising Number of Accountable Care Organizations
    • 4.4.2. Emergence of Cloud-Based Patient Registry Solutions
    • 4.4.3. Shifting Focus Towards Patient-Powered Research Networks (Pprns)
  • 4.5. Challenges
    • 4.5.1. Lack of Infrastucture & Awareness In Developing Regions
    • 4.5.2. Lack of Interoperability

5. Patient Registry Software Market, by Registry Type

  • 5.1. Introduction
  • 5.2. Disease Registries
    • 5.2.1. Cardiovascular Registries
    • 5.2.2. Diabetes Registries
    • 5.2.3. Cancer Registries
    • 5.2.4. Rare Disease Registries
    • 5.2.5. Asthma Registries
    • 5.2.6. Chronic Kidney Disease Registries
    • 5.2.7. Orthopedic Registries
    • 5.2.8. Others
  • 5.3. Health Service Registries
  • 5.4. Product Registries
    • 5.4.1. Medical Device Registries
    • 5.4.2. Drug Registries

6. Patient Registry Software Market, by Software Type

  • 6.1. Introduction
  • 6.2. Standalone Software
  • 6.3. Integrated Software

7. Patient Registry Software Market, by Pricing Model

  • 7.1. Introduction
  • 7.2. Subscription Model
  • 7.3. Ownership Model

8. Patient Registry Software Market, by Deployment Model

  • 8.1. Introduction
  • 8.2. On-Premises
  • 8.3. Web & Cloud-Based

9. Patient Registry Software Market, by Database Type

  • 9.1. Introduction
  • 9.2. Commercial Database
  • 9.3. Public Database

10. Patient Registry Software Market, by Functionality

  • 10.1. Introduction
  • 10.2. Population Health Management
  • 10.3. Patient Care Management
  • 10.4. Health Information Exchange
  • 10.5. Point-Of-Care
  • 10.6. Product Outcome Evaluation
  • 10.7. Medical Research & Clinical Studies

11. Patient Registry Software Market, by End-User

  • 11.1. Introduction
  • 11.2. Government Organizations & Third-Party Administrators
  • 11.3. Hospitals And Medical Practices
  • 11.4. Private Payers
  • 11.5. Pharmaceutical, Biotechnology, And Medical Device Companies
  • 11.6. Research Centers

12. Patient Registry Software Market, by Geography

  • 12.1. Introduction
  • 12.2. North America
    • 12.2.1. U.S.
    • 12.2.2. Canada
  • 12.3. Europe
    • 12.3.1. U.K
    • 12.3.2. Germany
    • 12.3.3. France
    • 12.3.4. Italy
    • 12.3.5. Spain
    • 12.3.6. RoE
  • 12.4. Apac
    • 12.4.1. Japan
    • 12.4.2. China
    • 12.4.3. India
    • 12.4.4. Roapac
  • 12.5. RoW
    • 12.5.1. Latin America
    • 12.5.2. Middle East & Africa

13. Competitive Landscape

  • 13.1. Partnerships, Agreements, Strategic Alliances & Collaborations
  • 13.2. New Product/Service Launch, Enhancements & Upgradations
  • 13.3. Mergers & Acquistions
  • 13.4. Expansion

14. Company Profiles

  • 14.1. Phytel, Inc.
    • 14.1.1. Business Overview
    • 14.1.2. Financial Overview
    • 14.1.3. Product Portfolio
    • 14.1.4. Strategic Developments
  • 14.2. FIGmd, Inc.
    • 14.2.1. Business Overview
    • 14.2.2. Financial Overview
    • 14.2.3. Product Portfolio
    • 14.2.4. Strategic Developments
  • 14.3. Liaison Technologies
    • 14.3.1. Business Overview
    • 14.3.2. Financial Overview
    • 14.3.3. Product Portfolio
    • 14.3.4. Strategic Developments
  • 14.4. Cecity.Com, Inc.
    • 14.4.1. Business Overview
    • 14.4.2. Financial Overview
    • 14.4.3. Product Portfolio
    • 14.4.4. Strategic Developments
  • 14.5. Dacima Software Inc.
    • 14.5.1. Business Overview
    • 14.5.2. Financial Overview
    • 14.5.3. Product Portfolio
    • 14.5.4. Strategic Developments
  • 14.6. Global Vision Technologies, Inc.
    • 14.6.1. Business Overview
    • 14.6.2. Financial Overview
    • 14.6.3. Product Portfolio
    • 14.6.4. Strategic Developments
  • 14.7. ifa Systems AG
    • 14.7.1. Business Overview
    • 14.7.2. Financial Overview
    • 14.7.3. Product Portfolio
    • 14.7.4. Strategic Developments
  • 14.8. Syneos Health, Inc.
    • 14.8.1. Business Overview
    • 14.8.2. Financial Overview
    • 14.8.3. Product Portfolio
    • 14.8.4. Strategic Developments
  • 14.9. M2s, Inc.
    • 14.9.1. Business Overview
    • 14.9.2. Financial Overview
    • 14.9.3. Product Portfolio
    • 14.9.4. Strategic Developments
  • 14.10. Mckesson Corporation
    • 14.10.1. Business Overview
    • 14.10.2. Financial Overview
    • 14.10.3. Product Portfolio
    • 14.10.4. Strategic Developments
  • 14.11. Quintiles Ims Holdings, Inc.
    • 14.11.1. Business Overview
    • 14.11.2. Financial Overview
    • 14.11.3. Product Portfolio
    • 14.11.4. Strategic Developments
  • 14.12. Unitedhealth Group (Optum)
    • 14.12.1. Business Overview
    • 14.12.2. Financial Overview
    • 14.12.3. Product Portfolio
    • 14.12.4. Strategic Developments
  • 14.13. Evado Pty. Ltd.
    • 14.13.1. Business Overview
    • 14.13.2. Financial Overview
    • 14.13.3. Product Portfolio
    • 14.13.4. Strategic Developments
  • 14.14. Velos, Inc.
    • 14.14.1. Business Overview
    • 14.14.2. Financial Overview
    • 14.14.3. Product Portfolio
    • 14.14.4. Recent Developments
  • 14.15. Healthdiary Inc.
    • 14.15.1. Business Overview
    • 14.15.2. Financial Overview
    • 14.15.3. Product Portfolio
    • 14.15.4. Strategic Developments
  • 14.16. Lumedx
    • 14.16.1. Business Overview
    • 14.16.2. Financial Overview
    • 14.16.3. Product Portfolio
    • 14.16.4. Strategic Developments
  • 14.17. Imagetrend, Inc.
    • 14.17.1. Business Overview
    • 14.17.2. Financial Overview
    • 14.17.3. Product Portfolio
    • 14.17.4. Strategic Developments
  • 14.18. Phamax AG
    • 14.18.1. Business Overview
    • 14.18.2. Financial Overview
    • 14.18.3. Product Portfolio
    • 14.18.4. Strategic Developments
  • 14.19. Arbormetrix
    • 14.19.1. Business Overview
    • 14.19.2. Financial Overview
    • 14.19.3. Product Portfolio
    • 14.19.4. Strategic Developments

15. Appendix

List of Tables

  • Table 1 Global Patient Registry Software Market: Impact Analysis Of Market Drivers (2018-2023)
  • Table 2 List of Approved Devices by US FDA, 2018
  • Table 3 Global Patient Registry Software Market: Impact Analysis of Market Restraints (2018-2023)
  • Table 4 Global Patient Registry Software Market Size, by Registry Type, 2016-2023 (USD Million)
  • Table 5 Global Disease Registry Software Market Size, by Type 2016-2023 (USD Million)
  • Table 6 Global Disease Registries Market Size, by Country/Region, 2016-2023 (USD Million)
  • Table 7 Global Cvd Registries Market Size, by Country/Region, 2016-2023 (USD Million)
  • Table 8 Global Diabetes Registries Market Size, by Country/Region, 2016-2023 (USD Million)
  • Table 9 Global Cancer Registries Market Size, by Country/Region, 2016-2023 (USD Million)
  • Table 10 Global Rare Disease Registries Market Size, by Country/Region, 2016-2023 (USD Million)
  • Table 11 National Registries for Asthma
  • Table 12 Global Asthma Registries Market Size, by Country/Region, 2016-2023 (USD Million)
  • Table 13 Global Chronic Kidney Disease Registries Market Size, by Country/Region, 2016-2023 (USD Million)
  • Table 14 Global Orthopedic Registries Market Size, by Country/Region, 2016-2023 (USD Million)
  • Table 15 Global Other Registries Market Size, by Country/Region, 2016-2023 (USD Million)
  • Table 16 Global Health Service Registries Market Size, by Country/Region, 2016-2023 (USD Million)
  • Table 17 Global Product Registries Market Size, by Type, 2016-2023 (USD Million)
  • Table 18 Global Product Registries Market Size, by Country/Region, 2016-2023 (USD Million)
  • Table 19 Global Medical Device Registries Market Size, by Country/ Region, 2016-2023 (USD Million)
  • Table 20 Global Drug Registries Market Size, by Country/ Region, 2016-2023 (USD Million)
  • Table 21 Global Patient Registry Software Market Size, by Software Type, 2016-2023 (USD Million)
  • Table 22 Global Standalone Patient Registry Software Market Size, by Country/ Region, 2016-2023 (USD Million)
  • Table 23 Global Integrated Patient Registry Software Market Size, by Country/ Region, 2016-2023 (USD Million)
  • Table 24 Global Patient Registry Software Market Size, by Pricing Model, 2016-2023 (USD Million)
  • Table 25 Global Subscription Model Market Size, by Country/Region, 2016-2023 (USD Million)
  • Table 26 Global Ownership Model Market Size, by Country/Region, 2016-2023 (USD Million)
  • Table 27 Global Patient Registry Software Market Size, by Deployment Model, 2016-2023 (USD Million)
  • Table 28 Global On-Premises Patient Registry Software Market Size, by Country/ Region, 2016-2023 (USD Million)
  • Table 29 Global Web & Cloud-Based Patient Registry Software Market Size, by Country/ Region, 2016-2023 (USD Million)
  • Table 30 Global Patient Registry Software Market Size, by Database Type, 2016-2023 (USD Million)
  • Table 31 Global Patient Registry Software Market Size For Commercial Databases, by Country/ Region, 2016-2023 (USD Million)
  • Table 32 Global Patient Registry Software Market Size For Public Databases, by Country/ Region, 2016-2023 (USD Million)
  • Table 33 Global Patient Registry Software Market Size, by Functionality, 2016-2023 (USD Million)
  • Table 34 Global Patient Registry Software Market Size for Population Health Management, by Country/Region, 2016-2023 (USD Million)
  • Table 35 Global Patient Registry Software Market Size for Patient Care Management, by Country/Region, 2016-2023 (USD Million)
  • Table 36 Global Patient Registry Software Market Size for Health Information Exchange, by Country/Region, 2016-2023 (USD Million)
  • Table 37 Global Patient Registry Software Market Size for Point of Care, by Country/Region, 2016-2023 (USD Million)
  • Table 38 Global Patient Registry Software Market Size for Product Outcome Evaluation, by Country/Region, 2016-2023 (USD Million)
  • Table 39 Global Patient Registry Software Market Size for Medical Research And Clinical Studies, by Country/Region, 2016-2023 (USD Million)
  • Table 40 Global Patient Registry Software Market Size, by End-User, 2016-2023 (USD Million)
  • Table 41 U.S.: Significant Funding For PHM
  • Table 42 Global Patient Registry Software Market Size for Government Organizations & Third-Party Administrators, by Country/Region, 2016-2023 (USD Million)
  • Table 43 Global Patient Registry Software Market Size for Hospitals & Medical Practices, by Country/Region, 2016-2023 (USD Million)
  • Table 44 Global Patient Registry Software Market Size for Private Payers, by Country/Region, 2016-2023 (USD Million)
  • Table 45 Global Patient Registry Software Market Size for Pharmaceutical, Biotechnology, and Medical Device Companies, by Country/Region, 2016-2023 (USD Million)
  • Table 46 Global Patient Registry Software Market Size for Research Centres, by Country/Region, 2016-2023 (USD Million)
  • Table 47 Global Patient Registry Market, by Country/Region, 2016-2023 (USD Million)
  • Table 48 North America: Patient Registry Software Market Size, by Country, 2016-2023 (USD Million)
  • Table 49 North America: Market Size, by Registry Type, 2016-2023 (USD Million)
  • Table 50 North America: Market Size, by Disease Registries, 2016-2023 (USD Million)
  • Table 51 North America: Market Size, by Product Registries, 2016-2023 (USD Million)
  • Table 52 North America: Market Size, by Software Type, 2016-2023 (USD Million)
  • Table 53 North America: Market Size, by Pricing Model, 2016-2023 (USD Million)
  • Table 54 North America: Market Size, by Deployment Model, 2016-2023 (USD Million)
  • Table 55 North America: Market Size, by Database Type, 2016-2023 (USD Million)
  • Table 56 North America: Market Size, by Functionality, 2016-2023 (USD Million)
  • Table 57 North America: Market Size, by End User, 2016-2023 (USD Million)
  • Table 58 U.S.: Patient Registry Software Market Size, by Registry Type, 2016-2023 (USD Million)
  • Table 59 U.S.: Market Size, by Disease Registries, 2016-2023 (USD Million)
  • Table 60 U.S.: Market Size, by Product Registries, 2016-2023 (USD Million)
  • Table 61 U.S.: Market Size, by Software Type, 2016-2023 (USD Million)
  • Table 62 U.S.: Market Size, by Pricing Model, 2016-2023 (USD Million)
  • Table 63 U.S.: Market Size, by Deployment Model, 2016-2023 (USD Million)
  • Table 64 U.S.: Market Size, by Database Type, 2016-2023 (USD Million)
  • Table 65 U.S.: Market Size, by Functionality, 2016-2023 (USD Million)
  • Table 66 U.S.: Market Size, by End User, 2016-2023 (USD Million)
  • Table 67 Canada: Patient Registry Software Market Size, by Registry Type, 2016-2023 (USD Million)
  • Table 68 Canada: Market Size, by Disease Registries, 2016-2023 (USD Million)
  • Table 69 Canada: Market Size, by Product Registries, 2016-2023 (USD Million)
  • Table 70 Canada: Market Size, by Software Type, 2016-2023 (USD Million)
  • Table 71 Canada: Market Size, by Pricing Model, 2016-2023 (USD Million)
  • Table 72 Canada: Market Size, by Deployment Model, 2016-2023 (USD Million)
  • Table 73 Canada: Market Size, by Database Type, 2016-2023 (USD Million)
  • Table 74 Canada: Market Size, by Functionality, 2016-2023 (USD Million)
  • Table 75 Canada: Market Size, by End User, 2016-2023 (USD Million)
  • Table 76 Distribution Of Registries By Country, 2017
  • Table 77 Europe: Patient Registry Software Market Size, by Country, 2016-2023 (USD Million)
  • Table 78 Europe: Market Size, by Registry Type, 2016-2023 (USD Million)
  • Table 79 Europe: Market Size, by Disease Registries, 2016-2023 (USD Million)
  • Table 80 Europe: Market Size, by Product Registries, 2016-2023 (USD Million)
  • Table 81 Europe: Market Size, by Software Type, 2016-2023 (USD Million)
  • Table 82 Europe: Market Size, by Pricing Model, 2016-2023 (USD Million)
  • Table 83 Europe: Market Size, by Deployment Model, 2016-2023 (USD Million)
  • Table 84 Europe: Market Size, by Database Type, 2016-2023 (USD Million)
  • Table 85 Europe: Market Size, by Functionality, 2016-2023 (USD Million)
  • Table 86 Europe: Market Size, by End User, 2016-2023 (USD Million)
  • Table 87 U.K.: Patient Registry Software Market Size, by Registry Type, 2016-2023 (USD Million)
  • Table 88 U.K.: Market Size, by Disease Registries, 2016-2023 (USD Million)
  • Table 89 U.K.: Market Size, by Product Registries, 2016-2023 (USD Million)
  • Table 90 U.K.: Market Size, by Software Type, 2016-2023 (USD Million)
  • Table 91 U.K.: Market Size, by Pricing Model, 2016-2023 (USD Million)
  • Table 92 U.K.: Market Size, by Deployment Model, 2016-2023 (USD Million)
  • Table 93 U.K.: Market Size, by Database Type, 2016-2023 (USD Million)
  • Table 94 U.K.: Market Size, by Functionality, 2016-2023 (USD Million)
  • Table 95 U.K.: Market Size, by End User, 2016-2023 (USD Million)
  • Table 96 List Of Some Rare Diseases That Are Covered By The Listed Registries In Germany, 2017
  • Table 97 Germany: Patient Registry Software Market Size, by Registry Type, 2016-2023 (USD Million)
  • Table 98 Germany: Market Size, by Disease Registries, 2016-2023 (USD Million)
  • Table 99 Germany: Market Size, by Product Registries, 2016-2023 (USD Million)
  • Table 100 Germany: Market Size, by Software Type, 2016-2023 (USD Million)
  • Table 101 Germany: Market Size, by Pricing Model, 2016-2023 (USD Million)
  • Table 102 Germany: Market Size, by Deployment Model, 2016-2023 (USD Million)
  • Table 103 Germany: Market Size, by Database Type, 2016-2023 (USD Million)
  • Table 104 Germany: Market Size, by Functionality, 2016-2023 (USD Million)
  • Table 105 Germany: Market Size, by End User, 2016-2023 (USD Million)
  • Table 106 France: Patient Registry Software Market Size, by Registry Type, 2016-2023 (USD Million)
  • Table 107 France: Market Size, by Disease Registries, 2016-2023 (USD Million)
  • Table 108 France: Market Size, by Product Registries, 2016-2023 (USD Million)
  • Table 109 France: Market Size, by Software Type, 2016-2023 (USD Million)
  • Table 110 France: Market Size, by Pricing Model, 2016-2023 (USD Million)
  • Table 111 France: Market Size, by Deployment Model, 2016-2023 (USD Million)
  • Table 112 France: Market Size, by Database Type, 2016-2023 (USD Million)
  • Table 113 France: Market Size, by Functionality, 2016-2023 (USD Million)
  • Table 114 France: Market Size, by End User, 2016-2023 (USD Million)
  • Table 115 EHR Adoption In Italy, Based On Himss Analytics European Ehr Adoption Model, 2015
  • Table 116 Italy: Patient Registry Software Market Size, by Registry Type, 2016-2023 (USD Million)
  • Table 117 Italy: Market Size, by Disease Registries, 2016-2023 (USD Million)
  • Table 118 Italy: Market Size, by Product Registries, 2016-2023 (USD Million)
  • Table 119 Italy: Market Size, by Software Type, 2016-2023 (USD Million)
  • Table 120 Italy: Market Size, by Pricing Model, 2016-2023 (USD Million)
  • Table 121 Italy: Market Size, by Deployment Model, 2016-2023 (USD Million)
  • Table 122 Italy: Market Size, by Database Type, 2016-2023 (USD Million)
  • Table 123 Italy: Market Size, by Functionality, 2016-2023 (USD Million)
  • Table 124 Italy: Market Size, by End User, 2016-2023 (USD Million)
  • Table 125 Spain: Patient Registry Software Market Size, by Registry Type, 2016-2023 (USD Million)
  • Table 126 Spain: Market Size, by Disease Registries, 2016-2023 (USD Million)
  • Table 127 Spain: Market Size, by Product Registries, 2016-2023 (USD Million)
  • Table 128 Spain: Market Size, by Software Type, 2016-2023 (USD Million)
  • Table 129 Spain: Market Size, by Pricing Model, 2016-2023 (USD Million)
  • Table 130 Spain: Market Size, by Deployment Model, 2016-2023 (USD Million)
  • Table 131 Spain: Market Size, by Database Type, 2016-2023 (USD Million)
  • Table 132 Spain: Market Size, by Functionality, 2016-2023 (USD Million)
  • Table 133 Spain: Market Size, by End User, 2016-2023 (USD Million)
  • Table 134 ROE: Patient Registry Software Market Size, by Registry Type, 2016-2023 (USD Million)
  • Table 135 ROE: Market Size, by Disease Registries, 2016-2023 (USD Million)
  • Table 136 ROE: Market Size, by Product Registries, 2016-2023 (USD Million)
  • Table 137 ROE: Market Size, by Software Type, 2016-2023 (USD Million)
  • Table 138 ROE: Market Size, by Pricing Model, 2016-2023 (USD Million)
  • Table 139 ROE: Market Size, by Deployment Model, 2016-2023 (USD Million)
  • Table 140 ROE: Market Size, by Database Type, 2016-2023 (USD Million)
  • Table 141 ROE: Market Size, by Functionality, 2016-2023 (USD Million)
  • Table 142 ROE: Market Size, by End User, 2016-2023 (USD Million)
  • Table 143 APAC: Patient Registry Software Market Size, by Country, 2016-2023 (USD Million)
  • Table 144 APAC:Market Size, by Registry Type, 2016-2023 (USD Million)
  • Table 145 APAC: Market Size, by Disease Registries, 2016-2023 (USD Million)
  • Table 146 APAC: Market Size, by Product Registries, 2016-2023 (USD Million)
  • Table 147 APAC: Market Size, by Software Type, 2016-2023 (USD Million)
  • Table 148 APAC: Market Size, by Pricing Model, 2016-2023 (USD Million)
  • Table 149 APAC: Market Size, by Deployment Model, 2016-2023 (USD Million)
  • Table 150 APAC: Market Size, by Database Type, 2016-2023 (USD Million)
  • Table 151 APAC: Market Size, by Functionality, 2016-2023 (USD Million)
  • Table 152 APAC: Market Size, by End User, 2016-2023 (USD Million)
  • Table 153 Japan: Patient Registry Software Market Size, by Registry Type, 2016-2023 (USD Million)
  • Table 154 Japan: Market Size, by Disease Registries, 2016-2023 (USD Million)
  • Table 155 Japan: Market Size, by Product Registries, 2016-2023 (USD Million)
  • Table 156 Japan: Market Size, by Software Type, 2016-2023 (USD Million)
  • Table 157 Japan: Market Size, by Pricing Model, 2016-2023 (USD Million)
  • Table 158 Japan: Market Size, by Deployment Model, 2016-2023 (USD Million)
  • Table 159 Japan: Market Size, by Database Type, 2016-2023 (USD Million)
  • Table 160 Japan: Market Size, by Functionality, 2016-2023 (USD Million)
  • Table 161 Japan: Market Size, by End User, 2016-2023 (USD Million)
  • Table 162 China: Patient Registry Software Market Size, by Registry Type, 2016-2023 (USD Million)
  • Table 163 China: Market Size, by Disease Registries, 2016-2023 (USD Million)
  • Table 164 China: Market Size, by Product Registries, 2016-2023 (USD Million)
  • Table 165 China: Market Size, by Software Type, 2016-2023 (USD Million)
  • Table 166 China: Market Size, by Pricing Model, 2016-2023 (USD Million)
  • Table 167 China: Market Size, by Deployment Model, 2016-2023 (USD Million)
  • Table 168 China: Market Size, by Database Type, 2016-2023 (USD Million)
  • Table 169 China: Market Size, by Functionality, 2016-2023 (USD Million)
  • Table 170 China: Market Size, by End User, 2016-2023 (USD Million)
  • Table 171 List of Registries In India
  • Table 172 List The Various Stages of Model of HER in India
  • Table 173 India: Patient Registry Software Market Size, by Registry Type, 2016-2023 (USD Million)
  • Table 174 India: Market Size, by Disease Registries, 2016-2023 (USD Million)
  • Table 175 India: Market Size, by Product Registries, 2016-2023 (USD Million)
  • Table 176 India: Patient Registry Software Market Size, by Software Type, 2016-2023 (USD Million)
  • Table 177 India: Patient Registry Software Market Size, by Pricing Model, 2016-2023 (USD Million)
  • Table 178 India: Patient Registry Software Market Size, by Deployment Model, 2016-2023 (USD Million)
  • Table 179 India: Patient Registry Software Market Size, by Database Type, 2016-2023 (USD Million)
  • Table 180 India: Patient Registry Software Market Size, by Functionality, 2016-2023 (USD Million)
  • Table 181 India: Patient Registry Software Market Size, by End User, 2016-2023 (USD Million)
  • Table 182 RoAPAC: Patient Registry Software Market Size, by Registry Type, 2016-2023 (USD Million)
  • Table 183 RoAPAC: Patient Registry Software Market Size, by Disease Registries, 2016-2023 (USD Million)
  • Table 184 RoAPAC: Patient Registry Software Market Size, by Product Registries, 2016-2023 (USD Million)
  • Table 185 RoAPAC: Patient Registry Software Market Size, by Software Type, 2016-2023 (USD Million)
  • Table 186 RoAPAC: Patient Registry Software Market Size, by Pricing Model, 2016-2023 (USD Million)
  • Table 187 RoAPAC: Patient Registry Software Market Size, by Deployment Model, 2016-2023 (USD Million)
  • Table 188 RoAPAC: Patient Registry Software Market Size, by Database Type, 2016-2023 (USD Million)
  • Table 189 RoAPAC: Patient Registry Software Market Size, by Functionality, 2016-2023 (USD Million)
  • Table 190 RoAPAC: Patient Registry Software Market Size, by End User, 2016-2023 (USD Million)
  • Table 191 RoW: Patient Registry Software Market Size, by Country, 2016-2023 (USD Million)
  • Table 192 RoW: Patient Registry Software Market Size, by Registry Type, 2016-2023 (USD Million)
  • Table 193 RoW: Patient Registry Software Market Size, by Disease Registries, 2016-2023 (USD Million)
  • Table 194 RoW: Patient Registry Software Market Size, by Product Registries, 2016-2023 (USD Million)
  • Table 195 RoW: Patient Registry Software Market Size, by Software Type, 2016-2023 (USD Million)
  • Table 196 RoW: Patient Registry Software Market Size, by Pricing Model, 2016-2023 (USD Million)
  • Table 197 RoW: Patient Registry Software Market Size, by Deployment Model, 2016-2023 (USD Million)
  • Table 198 RoW: Patient Registry Software Market Size, by Database Type, 2016-2023 (USD Million)
  • Table 199 RoW: Patient Registry Software Market Size, by Functionality, 2016-2023 (USD Million)
  • Table 200 RoW: Patient Registry Software Market Size, by End User, 2016-2023 (USD Million)
  • Table 201 Latin America: Patient Registry Software Market Size, by Registry Type, 2016-2023 (USD Million)
  • Table 202 Latin America: Patient Registry Software Market Size, by Disease Registries, 2016-2023 (USD Million)
  • Table 203 Latin America: Patient Registry Software Market Size, by Product Registries, 2016-2023 (USD Million)
  • Table 204 Latin America: Patient Registry Software Market Size, by Software Type, 2016-2023 (USD Million)
  • Table 205 Latin America: Patient Registry Software Market Size, by Pricing Model, 2016-2023 (USD Million)
  • Table 206 Latin America: Patient Registry Software Market Size, by Deployment Model, 2016-2023 (USD Million)
  • Table 207 Latin America: Patient Registry Software Market Size, by Database Type, 2016-2023 (USD Million)
  • Table 208 Latin America: Patient Registry Software Market Size, by Functionality, 2016-2023 (USD Million)
  • Table 209 Latin America: Patient Registry Software Market Size, by End User, 2016-2023 (USD Million)
  • Table 210 Middle East & Africa: Patient Registry Software Market Size, by Registry Type, 2016-2023 (USD Million)
  • Table 211 Middle East & Africa: Patient Registry Software Market Size, by Disease Registries, 2016-2023 (USD Million)
  • Table 212 Middle East & Africa: Patient Registry Software Market Size, by Product Registries, 2016-2023 (USD Million)
  • Table 213 Middle East & Africa: Patient Registry Software Market Size, by Software Type, 2016-2023 (USD Million)
  • Table 214 Middle East & Africa: Patient Registry Software Market Size, by Pricing Model, 2016-2023 (USD Million)
  • Table 215 Middle East & Africa: Patient Registry Software Market Size, by Deployment Model, 2016-2023 (USD Million)
  • Table 216 Middle East & Africa: Patient Registry Software Market Size, by Database Type, 2016-2023 (USD Million)
  • Table 217 Middle East & Africa: Patient Registry Software Market Size, by Functionality, 2016-2023 (USD Million)
  • Table 218 Middle East & Africa: Patient Registry Software Market Size, by End User, 2016-2023 (USD Million)
  • Table 219 Number Of Developments Made by the Profiled Companies, 2015-April 2018
  • Table 220 Partnerships, Agreements, Strategic Alliances & Collaborations
  • Table 221 New Product/Service Launches, Enhancements & Upgradations
  • Table 222 Mergers & Acquistions
  • Table 223 Expansion

List of Figures

  • Figure 1 Market Ecosystem
  • Figure 2 Key Stakeholders Of Patient Registry Software Market
  • Figure 3 Research Process
  • Figure 4 Key Executives Interviewed
  • Figure 5 Primary Research Techniques
  • Figure 6 Market Size Estimation
  • Figure 7 Market Dynamics
  • Figure 8 Percentage Adoption Of EHR by the U.S. Physicians, 2006-2014
  • Figure 9 Percentage Adoption Of EHR in the U.S. Hospitals, 2006-2014
  • Figure 10 Number of ACOs in the U.S., 2014- January 2018
  • Figure 11 Global Patient Registry Software Market Size, by Software Type, 2016-2023 (USD Million)
  • Figure 12 Total Number of Registered Hospitals in Top Ten Countries, 2017
  • Figure 13 Global Patient Registry Software Market, by Country/Region, 2016-2023 (USD Million)
  • Figure 14 North America: Pateint Registry Software Market Size, by Country, 2016-2023 (USD Million)
  • Figure 15 Aging Population in the U.S., 2000-2016
  • Figure 16 Highlights of EHR Adoption in the U.S.
  • Figure 17 Proportion of the Population, 65 Years and Over in Canada, 2017-2031
  • Figure 18 Europe: Patient Registry Software Market Size, by Country, 2016-2023 (USD Million)
  • Figure 19 Annual Public Spending on Health in Real Terms in the U.K., 2016
  • Figure 20 Promising Tools for Population Health Management in the U.K.
  • Figure 21 Healthcare Spending in France, 2005-2015
  • Figure 22 Promising Tools for Population Health Management in Nordic Countries
  • Figure 23 APAC: Patient Registry Software Market Size, by Country, 2016-2023 (USD Million)
  • Figure 24 Number of Aging Population in Japan, 2015-2042
  • Figure 25 Total Medical Expenditure in Japan, 2017
  • Figure 26 Population Aged 60 or Above in China, 2017-2050
  • Figure 27 Healthcare Expenditure in China, 2014
  • Figure 28 RoW: Patient Registry Software Market Size, by Country, 2016-2023 (USD Million)
  • Figure 29 Healthcare Spending Per Head in Latin America, 2013-2017
  • Figure 30 Healthcare Spending in Latin American Countries, 2015-2017
  • Figure 31 Key Growth Strategies Adopted by Key Players -January 2015- April 2018
  • Figure 32 Partnerships, Agreements, Strategic Alliances & Collaborations
  • Figure 33 New Product/Service Launch, Enhancements & Upgradations
  • Figure 34 Mergers & Acquistions
  • Figure 35 Expansion
  • Figure 36 IBM Corporation: Financial Overview (2015-2017)
  • Figure 37 Ifa Systems Ag: Financial Overview (2014-2016)
  • Figure 38 Syneos Health Inc.: Financial Overview (2015-2017)
  • Figure 39 Mckesson Corporation: Financial Overview (2015-2017)
  • Figure 40 Quintiles IMS Holdings, Inc.: Financial Overview (2014-2016)
  • Figure 41 UnitedHealth Group: Financial Overview (2015-2017)
Back to Top